Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
9.07
-1.68 (-15.63%)
At close: Apr 28, 2026, 4:00 PM EDT
8.99
-0.08 (-0.88%)
Pre-market: Apr 29, 2026, 4:08 AM EDT
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 104 employees as of December 31, 2025. The number of employees increased by 15 or 16.85% compared to the previous year.
Employees
104
Change (1Y)
15
Growth (1Y)
16.85%
Revenue / Employee
n/a
Profits / Employee
-$806,394
Market Cap
224.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 104 | 15 | 16.85% |
| Dec 31, 2024 | 89 | 46 | 106.98% |
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Voyager Therapeutics | 141 |
| Heron Therapeutics | 128 |
| Orchestra BioMed Holdings | 86 |
| Keros Therapeutics | 78 |
| Camp4 Therapeutics | 48 |
| ALX Oncology Holdings | 43 |
| Milestone Pharmaceuticals | 38 |
| Fennec Pharmaceuticals | 35 |
ARTV News
- 13 days ago - Artiva Biotherapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 weeks ago - Artiva Biotherapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors - GlobeNewsWire
- 3 months ago - Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Continued Durability of AlloNK in NHL - GlobeNewsWire